SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021892
Filing Date
2022-11-03
Accepted
2022-11-03 16:17:37
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlay-20220930.htm   iXBRL 10-Q 3410899
2 EX-31.1 rlay-ex31_1.htm EX-31.1 22364
3 EX-31.2 rlay-ex31_2.htm EX-31.2 22304
4 EX-32.1 rlay-ex32_1.htm EX-32.1 21117
  Complete submission text file 0000950170-22-021892.txt   10307670

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20220930_lab.xml EX-101.LAB 400836
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlay-20220930_def.xml EX-101.DEF 185867
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20220930_pre.xml EX-101.PRE 302899
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20220930.xsd EX-101.SCH 47315
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlay-20220930_cal.xml EX-101.CAL 52718
52 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20220930_htm.xml XML 2133295
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 221358289
SIC: 2836 Biological Products, (No Diagnostic Substances)